Abstract:Objective To investigate the etiology composition of enterovirus (EV) in patients with severe hand, foot, and mouth disease (HFMD) in children. To assess the diagnostic value of cerebrospinal fluid (CSF) tests in severe HFMD, and to find the key laboratory tests for severe HFMD. Methods A total of 288 hospitalized cases of children clinically diagnosed with severe HFMD in Hangzhou Children′s Hospital were included from March to July 2016. Throat swabs were collected and enterovirus nucleic acids were detected by fluorescence quantitative reverse transcription (RT)-PCR. Synchronous CSF and serum samples were collected for EV-A71 and CV-sackievirus A16 (CV-A16)-IgM antibody detection. CSF samples underwent routine and biochemical tests. Normally distributed continuous variables were compared using t test. Non-normal distribution continuous variables were compared using Mann-Whitney U test. Differences between categorical variables were compared with χ2 test. Results The total positive rate of enterovirus nucleic acid EV-A71/CV-A16/EV by fluorescence quantitative RT-PCR in the 288 cases of children clinically diagnosed with HFMD was 83.7% (241/288), including EV-A71 55.2% (159/288), CV-A16 4.9% (14/288) and the other enterovirus 23.6% (68/288). Among the other enterovirus group, there were 29.4% CV-A6 (20/68) , 16.2% CV-A4 (11/68) and CV-A10 10.3% (7/68). The total positive rate of combined serum and CSF detection of EV nucleic acid and EV-A71 and CV-A16 IgM antibody was 98.3% (283/288). EV nucleic acid positive rate was 83.7% (24/288). The positive rates were statistically different (χ2 =37.289, P=0.000). The CSF nucleated cells count in EV-A71 positive subgroup was higher than those in CV-A16 positive subgroup and other enteroviruses subgroup (Z=-4.472 and -9.991, respectively, both P 400 mg/L) rate in EV-A71 positive subgroup was higher than those in CV-A16 positive subgroup and other enteroviruses subgroup (χ2=4.956 and 11.795, respectively, both P<0.05). The CSF nucleated cell counts and positive rates in EV-A71 IgM antibody-positive subgroup were both higher than those in antibody-negative subgroup (both P<0.05). The CSF protein level and elevated proportion in antibody-positive subgroup were both higher than those in antibody-negative subgroup (both P<0.05). The lactate dehydrogenase concentration in antibody-positive subgroup was significantly higher than those in antibody-negative subgroup (P<0.05). The EV-A71 IgM antibody in serum was significantly correlated with the antibody in CSF (r=0.600, P<0.05). Conclusions EV-A71 is still the most important pathogen of severe HFMD in Hangzhou in 2016. Other enterovirus such as CV-A6, CV-A4 increases compared to those in 2014 and 2015. The CSF routine and biochemical tests and the IgM antibody levels can serve as an important indicator for the diagnosis of children with severe HFMD. Key words: Hand, foot and mouth disease; Antibodies; Cerebrospinal fluid

Selection of candidate strains for hand, foot and mouth disease vaccine against enterovirus 71

Analysis of the Complete Genomes of Enterovirus 71 Subtypes in China.

PATHOGEN SPECTRUM ANALYSIS OF HAND, FOOT AND MOUTH DISEASE AND GENETIC ANALYSIS OF THE VP1 REGION OF HUMAN ENTEROVIRUS 71 ISOLATED STRAINS IN HANGZHOU

Epidemic Characteristics of Pathogen Spectrum and Cerebrospinal Fluid Analysis of Severe Hand , Foot , and Mouth Disease in Hangzhou ,2016

Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71

Sequencing and evolution analysis of enterovirus 71 VP1 gene in Hangzhou in 2016

Development of Novel Vaccines against Enterovirus-71

Molecular Epidemiology and Evolution of Worldwide Enterovirus 71 Strains Isolated from 1970 to 2004

Newly emerged enterovirus-A71 C4 sublineage may be more virulent than B5 in the 2015–2016 hand-foot-and-mouth disease outbreak in northern Vietnam

Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China.

Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD)

Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine

Enterovirus 71 vaccine: close but still far

Expression and Immunogenicity of Novel Subunit Enterovirus 71 Vp1 Antigens

Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease

Genetic Variation of Multiple Serotypes of Enteroviruses Associated with Hand, Foot and Mouth Disease in Southern China

The need for development of other enterovirus vaccines in addition to EV-A71 vaccine

Epidemiology of Hand, Foot and Mouth Disease in China, 2008 to 2015 Prior to the Introduction of EV-A71 Vaccine

Foot-and-mouth disease virus strains isolated in Vietnam during 2010-2019: genetic characterization and antigenic relatedness to the Euro SA vaccine

Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023

Two cases of hand, foot and mouth disease caused by enterovirus A71 after vaccination